Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Peloton Interactive Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.28 (market cap $5.08B), while Peloton Interactive Inc trades at $5.11 (market cap $2.22B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 2.3× Peloton Interactive Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Peloton Interactive Inc for 37 Days on average.
| ORKA | PTON | |
|---|---|---|
Market Cap | $5.08B | $2.22B |
Volume | 685,276 | 7,928,718 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $7.86 |
52-Week Low | $26.19 | $3.71 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $4.21B | $2.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Peloton (PTON) trades at $5.22, up 1.56% today, with a bullish technical signal and neutral oscillators. The company reported its first profitable year in 2026 with a net income margin of 2.58%, though recent quarterly earnings have been mixed. Revenue declined to $2.49B in 2025, but cash flow from operations improved to $333M. Analyst consensus is a buy with a $8.00 price target, and recent news highlights new product launches including a foldable treadmill.
The outlook is cautiously optimistic as cost-cutting drives profitability, but subscriber declines and high debt pose risks. Upside depends on successful product adoption and sustained margin improvement, while competition and execution missteps could pressure the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
